BlaidsX Neuro vs Lucid Ultra 128

The BlaidsX Neuro is a mid-priced behind-the-ear OTC hearing aid priced at $799, earning a B grade with a SoundScore of 3.4/5 in our lab testing. This places it in the top 68% of OTC hearing aids tested, though it falls below the category average of 3.71. In our testing, the BlaidsX Neuro showed notable strengths in speech clarity for quiet environments, scoring 0.54 points above the category average. Feedback handling was excellent at 5.0/5, ranking among the best we've measured and 0.46 points above average. These results suggest the device may work well for conversations in calm settings where background noise isn't a factor. However, the device showed significant limitations in other areas. Speech in noise performance scored low at 1.0/5, falling 0.48 points below the category average—a concern for users who need help in challenging listening environments. Own-voice comfort also scored below average at 1.7/5, and music streaming scored 0.0/5, making it unsuitable for those who want to stream audio content. At this price point, buyers face strong competition. Devices like the Sony CRE-E10 and Lexie B2 Plus offer substantially higher overall scores in the same price range. The BlaidsX Neuro may suit users who primarily need help with face-to-face conversation in quiet spaces and don't require streaming capabilities, but those seeking versatile performance should consider alternatives.

The Lucid Ultra 128 is a premium behind-the-ear prescription hearing aid priced at $5,000, earning an A grade with a SoundScore of 4.4/5 in our lab testing. It ranks #16 of 36 devices in the Prescription Hearing Aid category. Speech performance is a clear strength for the Ultra 128. In our testing, speech in quiet scored a strong 4.3/5, landing 1.03 points above the category average. Speech in noise measured 2.7/5—above the category average by 0.74 points, though mixed in absolute terms. These results suggest the device prioritizes intelligibility in everyday listening situations. The Ultra 128 does show notable weaknesses. Feedback handling scored just 1.7/5, falling 3.01 points below the category average of 4.71/5—a significant gap that prospective buyers should consider. Music streaming measured 2.3/5, slightly below the category average. Own-voice comfort was mixed at 2.9/5, though this sits just above the category norm. The device uses disposable batteries and supports streaming to both iPhone and Android. At this price point, buyers may want to compare against higher-scoring competitors like the Phonak Sphere Infinio (5.0/5) or Oticon Intent (4.85/5). The Lucid Ultra 128 may suit those who prioritize speech clarity in quieter environments and can work with their hearing care provider to manage its feedback limitations.